Skip to main content

Recombinant Mouse Wnt-9a Protein

R&D Systems, part of Bio-Techne | Catalog # 8148-WN

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
Carrier Free
8148-WN-025/CF

Catalog #
Availability
Size / Price
Qty
With Carrier
8148-WN-025

Key Product Details

Source

CHO

Accession #

Conjugate

Unconjugated

Applications

Bioactivity

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived mouse Wnt-9a protein
Tyr30-Gly365

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Tyr30

Predicted Molecular Mass

37 kDa

SDS-PAGE

36-43 kDa, reducing conditions

Activity

Measured by its ability to activate Wnt induced TCF reporter activity in HEK293 human embryonic kidney cells expressing human Frizzled-4 and human LRP-5.
The ED50 for this effect is 8-40 ng/mL.

Measured in a cell proliferation/survival assay using C3H10T1/2 mouse embryonic fibroblast cells.
The ED50 for this effect is 60-300 ng/mL.

Scientific Data Images for Recombinant Mouse Wnt-9a Protein

Wnt-9a Activates Wnt Signaling in HEK293 Cells.

Wnt-9a Activates Wnt Signaling in HEK293 Cells.

Recombinant Mouse Wnt-9a (Catalog # 8148-WN) activates TCF reporter activity in HEK293 human embryonic kidney cells expressing human Frizzled-4 and human LRP-5. The ED50 for this effect is 9-40 ng/mL.

Formulation, Preparation and Storage

Carrier Free
What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

Carrier: 8148-WN
Formulation Lyophilized from a 0.2 μm filtered solution in PBS, EDTA and CHAPS with BSA as a carrier protein.
Reconstitution Reconstitute at 250 μg/mL in PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Carrier Free: 8148-WN/CF
Formulation Lyophilized from a 0.2 μm filtered solution in PBS, EDTA and CHAPS.
Reconstitution Reconstitute at 250 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Wnt-9a

Wnt-9a (Wingless integration region 9a; also Wnt-14) is a cysteine-rich member of the Wnt family of secreted glycoproteins (1-4).  This family is rather large at 19 members, and although it is most often associated with embryogenesis, the Wnt family is now known to be also important in a number of related processes, including angiogenesis, wound healing, tissue remodeling, and cancer (2, 5-8). Wnt-9a represents a paralog (common ancestor; different function) to Wnt-9b/Wnt-14b which, in the mouse, are found on the same chromosome (2, 4). The mouse Wnt-9a precursor is 365 amino acids (aa) in length. It contains a 29 aa signal sequence coupled to a 336 aa mature region (aa 30-365) that is characterized by the presence of 24 Cys residues, two palmitoylation sites (Cys93 and Ser221), and one presumably utilized glycosylation site at Asn103 (4, 9). The glycosylation and palmitoylation appear essential for secretion and activity. Based on studies with other Wnts, the palmitic acid at Cys93 is essential for frizzled/FZD4, 7 and 9, WIF-1 activation, while Ser221 is necessary for secretion (10). Although the exact mechanism(s) for secretion is unclear, it would appear that Wnt-9a initially binds to a select GPCR (Evi) in the Golgi. As a complex, it is transported to the plasma membrane in where it is inserted, internalized, and budded-off in a microvesicle that returns to the cell membrane for release as an exosome (11). Over the mature region, mouse Wnt-9a is identical in aa sequence to rat Wnt-9a and shares 98% aa sequence identity with human Wnt-9a (12). With respect to its paralog (Wnt-9b), mouse Wnt-9a and -9b share only 65% aa sequence identity in the mature region (4, 13). Cells known to express Wnt-9a, either inducibly or constitutively, include skeletal muscle (14, 15), limb-bud mesenchyme (16), mammary epithelium (17, 18), embryonic hepatic stellate/Ito and sinusoidal endothelial cells (19), and cranial osteoblasts (20). There are an extraordinary number of receptors/binding proteins that have been identified for members of the Wnt family (1, 21, 22). To date, Wnt-9a has been reported to bind to Fzd4, 7 and 9 (19), WIF-1 (16), and MuSK in conjunction with LRP4 (15). Functionally, Wnt-9a is best known for its participation in joint formation (but not initiation). During the formation of cartilaginous tissue, Wnt-9a contributes to the process of cavitation where chondrogenic tissue undergoes apoptosis and remodeling to create a functional space (interzone; precursor to a joint) (23). Elsewhere in the embryo, Wnt-9a is posited to induce hepatocyte proliferation and promote the generation of glycogen through enzyme activity regulation (19). In addition, Wnt-9a is reported to induce acetylcholine receptor clustering in newly formed myotubes (15).

References

  1. Kikuchi, A. et al. (2007) Cell. Signal. 19:659.
  2. Katoh, M. (2007) Stem Cell Rev. 3:30.
  3. Katoh, M. (2002) Int. J. Oncol. 21:1269.
  4. Qian, J. et al. (2003) Genomics 81:34.
  5. Miller, J. (2002) Genome Biol. 3:Reviews3001.
  6. Newman, A.C. & C.W. Hughes (2012) Vasc. Cell 4:13.
  7. Miao, C. et al. (2013) Cell. Signal. 25:2069.
  8. Bielefeld, K.A. et al. (2013) Cell. Mol. Life Sci. 70:2059.
  9. SwissProt #:Q8R5M2.
  10. Ke, J. et al. (2013) Curr. Opin. Lipidol. 24:129.
  11. Gross, J.C. et al. (2013) Nat. Cell Biol.  14:1036.
  12. Katoh, Y. & M. Katoh (2005) Oncol. Rep. 13:989.
  13. Kirikoshi, H. et al. (2001) Int. J. Oncol. 19:947.
  14. Saitoh, T. et al. (2001) Biochem. Biophys. Res. Commun. 284:1168.
  15. Zhang, B. et al. (2012) Mol. Brain 5:7.
  16. Surmann-Schmitt, C. et al. (2009) J. Cell Sci. 122:3627.
  17. Benhaj, K. et al. (2006) Oncol. Rep. 15:701.
  18. Witte, F. et al. (2009) Gene Exp. Patterns 9:215.
  19. Matsumoto, K. et al. (2008) Dev. Biol. 319:234.
  20. Zhou, H. et al. (2009) Development 136:427.
  21. Hendrickx, M & L. Leyns (2008) Develop. Growth Differ. 50:229.
  22. Kawano, Y & R. Kypta (2003) J. Cell Sci. 116:2627.
  23. Spater, D. et al. (2006) Development 133:3039.

Long Name

Wingless-type MMTV Integration Site Family, Member 9A

Alternate Names

Wnt-14, Wnt9a

Entrez Gene IDs

7483 (Human); 216795 (Mouse)

Gene Symbol

WNT9A

UniProt

Additional Wnt-9a Products

Product Documents for Recombinant Mouse Wnt-9a Protein

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Mouse Wnt-9a Protein

For research use only

Loading...
Loading...
Loading...